Jeffrey Newcorn
Director, Division of ADHD and Learning Disorders Icahn School of Medicine at Mount Sinai · Icahn School of Medicine at Mount Sinai
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Jeffrey Newcorn as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 23:29 UTC. Open this list on ClinicalTrials.gov
- N/ANCT06728969 · A Comparative Study to Evaluate a Novel Algorithm As a Diagnostic Aid for ADHD in Youth Ages 6-17.MindTension · recruiting · ADHD · principal investigator
- Ph4NCT04170738 · Brain Indices of Stimulant Treatment in Drug-Naive Youth at Risk for Substance Use DisorderJeffrey Newcorn · completed · Attention Deficit Disorder With Hyperactivity, Conduct Disorder, Substance Abuse · principal investigator
- Ph4NCT03781765 · Stimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD RiskIcahn School of Medicine at Mount Sinai · unknown · ADHD, Attention Deficit Hyperactivity Disorder · principal investigator
- Ph4NCT03781752 · Carboxylesterase 1 Genetic Variation and Methylphenidate in ADHDIcahn School of Medicine at Mount Sinai · unknown · ADHD, Attention Deficit Hyperactivity Disorder · principal investigator
- Ph3NCT02477748 · The MEASURE Study - A Phase 3 Study of MDX 1400 mg Daily Compared With Placebo in Adults With ADHDAlcobra Ltd. · terminated · Attention Deficit Hyperactivity Disorder (ADHD) · principal investigator
- N/ANCT02473419 · Neurobiological Basis of Response to Vayarin in Adults With ADHD: an fMRI Study of Brain Activation Pre and Post TreatmentIcahn School of Medicine at Mount Sinai · completed · ADHD · principal investigator
- Ph4NCT01924429 · Neurobiological Basis of Response to Vyvanse in Adults With ADHD: an fMRI Study of Brain ActivationJeffrey Newcorn · completed · ADHD · principal investigator
- Ph4NCT01709695 · Neurobiological Basis of Response to Guanfacine Extended Release in Children and Adolescents With ADHDIcahn School of Medicine at Mount Sinai · completed · ADHD, Attention Deficit Hyperactivity Disorder · principal investigator
- Ph4NCT01678209 · Imaging Stimulant and Non Stimulant Treatments for ADHD: A Network Based ApproachIcahn School of Medicine at Mount Sinai · completed · Attention Deficit Hyperactivity Disorder, ADHD · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-11 23:29 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 1 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Brain Indices of Stimulant Treatment in Drug-Naive Youth at Risk for Substance Use DisorderR21DA046029 · NIDA · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · fiscal years 2019 to 2020 · $211,875 awarded in 2020Grant number is on one of their registry trials
- Stimulant vs. non-stimulant treatments and reward processing in drug-naive youth at SUD riskR21DA045218 · NIDA · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · fiscal years 2018 to 2019 · $211,875 awarded in 2019Grant number is on one of their registry trials
- Imaging Stimulant and NonStimulant Treatments for ADHD: A Network-Based ApproachR01MH095766 · NIMH · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · fiscal years 2012 to 2016 · $540,613 awarded in 2016Grant number is on one of their registry trials
- MEASURING AND PREDICTING RESPONSE TO ATOMOXETINE AND METHYLYPHENIDATEM01RR000071 · NCRR · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · fiscal years 2007 to 2009 · $18,840 awarded in 2009Same name and institution; not confirmed by an ID
- Predicting Response to Atomoxetine and MethlyphenidateR01MH070935 · NIMH · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · fiscal years 2005 to 2009 · $597,413 awarded in 2009Same name and institution; not confirmed by an ID
- Dopamine and ADHD: A Research Infrastructure NetworkR21MH066360 · NIMH · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · fiscal years 2002 to 2004 · $234,770 awarded in 2004Same name and institution; not confirmed by an ID
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Carboxylesterase 1 Genetic Variation and Methylphenidate in ADHDR01HD093612 · NICHD · UNIVERSITY OF FLORIDA · PI JOHN S MARKOWITZ, Haojie Zhu · fiscal years 2018 to 2022Named on NCT03781752
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 23:29 UTC. The ranking covers the 200 most relevant of 77 PubMed records, and a shared surname and initials can bring in a namesake. All 77 on PubMed
- The MTA at 8 years: prospective follow-up of children treated for combined-type ADHD in a multisite study.J Am Acad Child Adolesc Psychiatry · 2009724 citationsRCR 27.0
- Once-daily atomoxetine treatment for children and adolescents with attention deficit hyperactivity disorder: a randomized, placebo-controlled study.Am J Psychiatry · 2002437 citationsRCR 14.9
- 3-year follow-up of the NIMH MTA study.J Am Acad Child Adolesc Psychiatry · 2007362 citationsRCR 12.9
- Findings from the NIMH Multimodal Treatment Study of ADHD (MTA): implications and applications for primary care providers.J Dev Behav Pediatr · 2001318 citationsRCR 11.5
- Atomoxetine and osmotically released methylphenidate for the treatment of attention deficit hyperactivity disorder: acute comparison and differential response.Am J Psychiatry · 2008237 citationsRCR 8.3
- Validity of the age-of-onset criterion for ADHD: a report from the DSM-IV field trials.J Am Acad Child Adolesc Psychiatry · 1997225 citationsRCR 9.3
- Medication treatment strategies in the MTA Study: relevance to clinicians and researchers.J Am Acad Child Adolesc Psychiatry · 1996211 citationsRCR 8.8
- Impairment and deportment responses to different methylphenidate doses in children with ADHD: the MTA titration trial.J Am Acad Child Adolesc Psychiatry · 2001206 citationsRCR 7.1
- Atomoxetine and methylphenidate treatment in children with ADHD: a prospective, randomized, open-label trial.J Am Acad Child Adolesc Psychiatry · 2002204 citationsRCR 6.8
- Effects of stimulant medication on growth rates across 3 years in the MTA follow-up.J Am Acad Child Adolesc Psychiatry · 2007196 citationsRCR 7.0